The study reveals that IBM factory workers were more likely to have died of cancer, including brain, kidney or breast cancer and non-Hodgkin’s lymphoma, than the rest of the population. The author of the study cannot link these deaths to any specific chemicals or other toxic exposures. The current study confirms previous, smaller studies and highlights clear health risks for workers in computer factories across the world.
Richard Clapp, from the Boston University School of Public Health, USA, studied the causes of death among all IBM factory workers who had worked for the company for at least five years between 1969 and 2001. Clapp analysed the causes of death for 31,941 workers and compared them with causes of death among the American population during this period. The data were obtained from the IBM corporation as part of a California lawsuit against IBM, and the plaintiffs' attorneys contracted with Clapp to carry out the analysis.
The results of Clapp’s analysis indicate that there was increased mortality due to several types of cancer, especially in manufacturing workers and workers at particular plants in California, Minnesota, New York, and Vermont. Most notably, there was an excess of deaths due to cancer of the brain and central nervous system. Kidney cancer, non-Hodgkin's lymphoma and breast cancer were also found in excess in some groups of workers. It was not possible to link these deaths to specific chemicals or other exposures in the workplace because the information necessary to do this was not available.
The study confirms a small mortality study of just three IBM plants published a year ago by company consultants, which also showed increased deaths due to brain and central nervous system cancer.
Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University
New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.
The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
22.03.2018 | Trade Fair News
22.03.2018 | Earth Sciences
22.03.2018 | Earth Sciences